Open-House-Biologika-Discount Agreements 2026-11 - Infliximab (Pharmaceutical form for intravenous application)
Open-House-Biologika-Rabattverträge 2026-11 - Infliximab (Darreichungsform zur intravenösen Anwendung)
Germany
Contract
BuyerTechniker Krankenkasse
TypeSupplies
Estimated valuevalue not published
Published19 April 2026
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Computacenter AG & Co. oHG | 76 | 2006–2026 |
| Siehe im Feld "Allgemeine Informationen" | 55 | 2023–2026 |
| Hexal AG · Holzkirchen | 43 | 2011–2026 |
| Aliud Pharma GmbH · Laichingen | 38 | 2011–2025 |
| Aristo Pharma GmbH · Berlin | 33 | 2012–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201986
202036
202122
202229
202354
2024263
20251
2025550
2026275
Who knows the rhythm prepares instead of reacting.
651
days until the deadline — Wednesday 31 May at 21:58
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →